165 related articles for article (PubMed ID: 25343839)
1. The potential of alkaline phosphatase as a treatment for sepsis-associated acute kidney injury.
Peters E; Masereeuw R; Pickkers P
Nephron Clin Pract; 2014; 127(1-4):144-8. PubMed ID: 25343839
[TBL] [Abstract][Full Text] [Related]
2. Alkaline phosphatase: a possible treatment for sepsis-associated acute kidney injury in critically ill patients.
Peters E; Heemskerk S; Masereeuw R; Pickkers P
Am J Kidney Dis; 2014 Jun; 63(6):1038-48. PubMed ID: 24462020
[TBL] [Abstract][Full Text] [Related]
3. Alkaline phosphatase as a treatment of sepsis-associated acute kidney injury.
Peters E; van Elsas A; Heemskerk S; Jonk L; van der Hoeven J; Arend J; Masereeuw R; Pickkers P
J Pharmacol Exp Ther; 2013 Jan; 344(1):2-7. PubMed ID: 23131595
[TBL] [Abstract][Full Text] [Related]
4. Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury: A Randomized Clinical Trial.
Pickkers P; Mehta RL; Murray PT; Joannidis M; Molitoris BA; Kellum JA; Bachler M; Hoste EAJ; Hoiting O; Krell K; Ostermann M; Rozendaal W; Valkonen M; Brealey D; Beishuizen A; Meziani F; Murugan R; de Geus H; Payen D; van den Berg E; Arend J;
JAMA; 2018 Nov; 320(19):1998-2009. PubMed ID: 30357272
[TBL] [Abstract][Full Text] [Related]
5. Alkaline phosphatase protects against renal inflammation through dephosphorylation of lipopolysaccharide and adenosine triphosphate.
Peters E; Geraci S; Heemskerk S; Wilmer MJ; Bilos A; Kraenzlin B; Gretz N; Pickkers P; Masereeuw R
Br J Pharmacol; 2015 Oct; 172(20):4932-45. PubMed ID: 26222228
[TBL] [Abstract][Full Text] [Related]
6. Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associated acute kidney injury.
Pickkers P; Angus DC; Arend J; Bellomo R; van den Berg E; Bernholz J; Bestle M; Broglio K; Carlsen J; Doig CJ; Ferrer R; Joannidis M; Francois B; Doi K; Kellum JA; Laterre PF; Liu K; Mehta RL; Murray PT; Ostermann M; Pettilä V; Richards S; Young P; Zarbock A; Kjølbye AL
BMJ Open; 2023 Apr; 13(4):e065613. PubMed ID: 37012016
[TBL] [Abstract][Full Text] [Related]
7. Effects of a human recombinant alkaline phosphatase on renal hemodynamics, oxygenation and inflammation in two models of acute kidney injury.
Peters E; Ergin B; Kandil A; Gurel-Gurevin E; van Elsas A; Masereeuw R; Pickkers P; Ince C
Toxicol Appl Pharmacol; 2016 Dec; 313():88-96. PubMed ID: 27760303
[TBL] [Abstract][Full Text] [Related]
8. Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial.
Pickkers P; Heemskerk S; Schouten J; Laterre PF; Vincent JL; Beishuizen A; Jorens PG; Spapen H; Bulitta M; Peters WH; van der Hoeven JG
Crit Care; 2012 Jan; 16(1):R14. PubMed ID: 22269279
[TBL] [Abstract][Full Text] [Related]
9. Human recombinant alkaline phosphatase inhibits ex vivo platelet activation in humans.
Tunjungputri RN; Peters E; van der Ven A; de Groot PG; de Mast Q; Pickkers P
Thromb Haemost; 2016 Nov; 116(6):1111-1121. PubMed ID: 27656709
[TBL] [Abstract][Full Text] [Related]
10. Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL).
Pickkers P; Angus DC; Bass K; Bellomo R; van den Berg E; Bernholz J; Bestle MH; Doi K; Doig CJ; Ferrer R; Francois B; Gammelager H; Pedersen UG; Hoste E; Iversen S; Joannidis M; Kellum JA; Liu K; Meersch M; Mehta R; Millington S; Murray PT; Nichol A; Ostermann M; Pettilä V; Solling C; Winkel M; Young PJ; Zarbock A;
Intensive Care Med; 2024 Jan; 50(1):68-78. PubMed ID: 38172296
[TBL] [Abstract][Full Text] [Related]
11. Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI).
Peters E; Mehta RL; Murray PT; Hummel J; Joannidis M; Kellum JA; Arend J; Pickkers P
BMJ Open; 2016 Sep; 6(9):e012371. PubMed ID: 27678541
[TBL] [Abstract][Full Text] [Related]
12. Sepsis and inflammation: impact on acute kidney injury.
Dirkes S
Nephrol Nurs J; 2013; 40(2):125-32; quiz 133. PubMed ID: 23767336
[TBL] [Abstract][Full Text] [Related]
13. Innovative Drugs to Target Renal Inflammation in Sepsis: Alkaline Phosphatase.
Hümmeke-Oppers F; Hemelaar P; Pickkers P
Front Pharmacol; 2019; 10():919. PubMed ID: 31507417
[TBL] [Abstract][Full Text] [Related]
14. Renal cell apoptosis and new treatment options in sepsis-induced acute kidney injury.
Koçkara A; Kayataş M
Ren Fail; 2013; 35(2):291-4. PubMed ID: 23181751
[TBL] [Abstract][Full Text] [Related]
15. Emerging therapeutic targets of sepsis-associated acute kidney injury.
Swaminathan S; Rosner MH; Okusa MD
Semin Nephrol; 2015 Jan; 35(1):38-54. PubMed ID: 25795498
[TBL] [Abstract][Full Text] [Related]
16. Effects of a human recombinant alkaline phosphatase during impaired mitochondrial function in human renal proximal tubule epithelial cells.
Peters E; Schirris T; van Asbeck AH; Gerretsen J; Eymael J; Ashikov A; Adjobo-Hermans MJ; Russel F; Pickkers P; Masereeuw R
Eur J Pharmacol; 2017 Feb; 796():149-157. PubMed ID: 28012971
[TBL] [Abstract][Full Text] [Related]
17. Recent early clinical drug development for acute kidney injury.
Gallagher KM; O'neill S; Harrison EM; Ross JA; Wigmore SJ; Hughes J
Expert Opin Investig Drugs; 2017 Feb; 26(2):141-154. PubMed ID: 27997816
[TBL] [Abstract][Full Text] [Related]
18. Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients.
Heemskerk S; Masereeuw R; Moesker O; Bouw MP; van der Hoeven JG; Peters WH; Russel FG; Pickkers P;
Crit Care Med; 2009 Feb; 37(2):417-23, e1. PubMed ID: 19114895
[TBL] [Abstract][Full Text] [Related]
19. Effect of alkaline phosphatase on sepsis-associated acute kidney injury patients: A systematic review and meta-analysis.
Tang W; Huang J; Huang X; Han X; Tang W; Ke G; Xu Q
Medicine (Baltimore); 2020 Jan; 99(4):e18788. PubMed ID: 31977869
[TBL] [Abstract][Full Text] [Related]
20. Bovine intestinal alkaline phosphatase attenuates the inflammatory response in secondary peritonitis in mice.
van Veen SQ; van Vliet AK; Wulferink M; Brands R; Boermeester MA; van Gulik TM
Infect Immun; 2005 Jul; 73(7):4309-14. PubMed ID: 15972524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
